Kyle Lefkoff, Director at ARRAY BIOPHARMA INC (ARRY), sold 14,000 shares at $3.31 ($33K) on 2010-11-16, disclosed to the SEC on 2010-11-18.
Open-market sale of $33k ARRY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 4,000 | $0 | 0.0% |
| 2 | $3.31 | 5,000 | $17K | 50.6% |
| 3 | $3.28 | 3,000 | $10K | 30.1% |
| 4 | $3.17 | 2,000 | $6K | 19.4% |
| Total | $2.34 avg | 14,000 | $33K | 100% |
| Filing → |
| ARRY | SELL | 2018-02-12 | $1.7M | — | Filing → |
| ARRY | SELL | 2017-09-29 | $957K | — | Filing → |
| ARRY | SELL | 2017-04-04 | $401K | — | Filing → |